Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Oskam

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 10, 2023
Heteroscedasticity of residual spending after risk equalization: a potential source of selection incentives in health insurance markets with premium regulationMichel Oskam, Richard C van Kleef, Rudy Douven
International Journal of Health Economics and Management|March 1, 2023
Improving diagnosis-based cost groups in the Dutch risk equalization model: the effects of a new clustering method and allowing for multimorbidityMichel Oskam, Richard C van Kleef, René C J A van Vliet
Medical Care Research and Review : MCRR|November 14, 2025
Does Health-Based Prospective Risk Adjustment Adequately Compensate for Individuals Diagnosed With a New Chronic Disease?Michel Oskam, Richard C van Kleef, René C J A van Vliet
Medical Care|December 4, 2023
Risk Adjustment in Health Insurance Markets: Do Not Overlook the "Real" HealthyRichard C van Kleef, René C J A van Vliet, Michel Oskam
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 10, 2023
Heteroscedasticity of residual spending after risk equalization: a potential source of selection incentives in health insurance markets with premium regulationMichel Oskam, Richard C van Kleef, Rudy Douven
International Journal of Health Economics and Management|March 1, 2023
Improving diagnosis-based cost groups in the Dutch risk equalization model: the effects of a new clustering method and allowing for multimorbidityMichel Oskam, Richard C van Kleef, René C J A van Vliet
Medical Care Research and Review : MCRR|November 14, 2025
Does Health-Based Prospective Risk Adjustment Adequately Compensate for Individuals Diagnosed With a New Chronic Disease?Michel Oskam, Richard C van Kleef, René C J A van Vliet
Medical Care|December 4, 2023
Risk Adjustment in Health Insurance Markets: Do Not Overlook the "Real" HealthyRichard C van Kleef, René C J A van Vliet, Michel Oskam
Pageof 1